デフォルト表紙
市場調査レポート
商品コード
1014880

大腸癌治療薬の世界市場:COVID-19の影響・回復への道筋 (~2030年)

Colorectal Cancer Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030

出版日: 受注後作成 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=116.46円
大腸癌治療薬の世界市場:COVID-19の影響・回復への道筋 (~2030年)
出版日: 受注後作成
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の大腸癌治療薬の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、タイプ・流通経路・クラス・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイル、成長機会、各種提言などをまとめています。

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向・市場戦略

第4章 COVID-19の影響

第5章 市場分析・予測

  • 市場規模の推移・予測
  • 市場成長推進因子
  • 市場成長抑制因子

第6章 市場分析・予測:各種区分別

  • タイプ別
  • VEGF阻害剤
  • EGFR阻害剤
  • PD1/PDL1阻害剤
  • BRAF・MEK阻害剤
  • チロシンキナーゼ(TKI)阻害剤
  • 免疫調節剤
  • 流通経路別
  • 病院薬局
  • 小売薬局
  • その他
  • クラス別
  • 免疫療法
  • 化学療法
  • その他

第7章 市場分析・予測:地域・国別

第8章 アジア太平洋市場の分析・予測

  • 市場概要
  • 地域情報・COVID-19の影響・市場情報・背景情報・政府イニシアチブ・法規制・機関&協会・租税・投資・主要企業
  • 市場分析・予測:タイプ別
  • 市場分析・予測:流通経路別

第9章 中国市場の分析・予測

  • 市場概要
  • 市場分析・予測:タイプ別
  • 市場分析・予測:流通経路別

第10章 インド市場の分析・予測

  • 市場分析・予測:タイプ別
  • 市場分析・予測:流通経路別

第11章 日本市場の分析・予測

  • 市場分析・予測:タイプ別
  • 市場分析・予測:流通経路別

第12章 オーストラリア市場の分析・予測

  • 市場分析・予測:タイプ別
  • 市場分析・予測:流通経路別

第13章 インドネシア市場の分析・予測

  • 市場分析・予測:タイプ別
  • 市場分析・予測:流通経路別

第14章 韓国市場の分析・予測

  • 市場分析・予測:タイプ別
  • 市場分析・予測:流通経路別

第15章 西欧市場の分析・予測

  • 市場概要
  • 市場分析・予測:タイプ別
  • 市場分析・予測:流通経路別

第16章 英国市場の分析・予測

  • 市場分析・予測:タイプ別
  • 市場分析・予測:流通経路別

第17章 ドイツ市場の分析・予測

  • 市場分析・予測:タイプ別
  • 市場分析・予測:流通経路別

第18章 フランス市場の分析・予測

  • 市場分析・予測:タイプ別
  • 市場分析・予測:流通経路別

第19章 東欧市場の分析・予測

  • 市場概要
  • 市場分析・予測:タイプ別
  • 市場分析・予測:流通経路別

第20章 ロシア市場の分析・予測

  • 市場分析・予測:タイプ別
  • 市場分析・予測:流通経路別

第21章 北米市場の分析・予測

  • 市場概要
  • 市場分析・予測:タイプ別
  • 市場分析・予測:流通経路別

第22章 米国市場の分析・予測

  • 市場概要
  • 市場分析・予測:タイプ別
  • 市場分析・予測:流通経路別

第23章 南米市場の分析・予測

  • 市場概要
  • 市場分析・予測:タイプ別
  • 市場分析・予測:流通経路別

第24章 ブラジル市場の分析・予測

  • 市場分析・予測:タイプ別
  • 市場分析・予測:流通経路別

第25章 中東市場の分析・予測

  • 市場概要
  • 市場分析・予測:タイプ別
  • 市場分析・予測:流通経路別

第26章 アフリカ市場の分析・予測

  • 市場概要
  • 市場分析・予測:タイプ別
  • 市場分析・予測:流通経路別

第27章 競合情勢・企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • Merck & Co. Inc
    • Roche
    • Sanofi
    • Amgen
    • PFIZER, INC.

第28章 パイプライン分析

第29章 M&A

第30章 将来の展望・潜在性の分析

第31章 付録

目次

Colorectal Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global colorectal cancer drugs market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the colorectal cancer drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Colorectal Cancer Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Type: Vascular Endothelial Growth Factor (VEGF) Inhibitors; Epidermal Growth Factor Receptor (EGFR) Inhibitors; Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors; BRAF or MEK Inhibitors; Tyrosine Kinase (TKI) Inhibitors; Immunomodulators

2) By Distribution Channels: Hospitals Pharmacies; Retail Pharmacies; Others

3) By Class: Immunotherapy; Chemotherapy; Others

Companies Mentioned: Merck & Co. Inc; Roche; Sanofi; Amgen; PFIZER

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Colorectal Cancer Drugs Market Characteristics

3. Colorectal Cancer Drugs Market Trends And Strategies

4. Impact Of COVID-19 On Colorectal Cancer Drugs

5. Colorectal Cancer Drugs Market Size And Growth

  • 5.1. Global Colorectal Cancer Drugs Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Colorectal Cancer Drugs Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Colorectal Cancer Drugs Market Segmentation

  • 6.1. Global Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Vascular Endothelial Growth Factor (VEGF) Inhibitors
  • Epidermal Growth Factor Receptor (EGFR) Inhibitors
  • Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
  • BRAF or MEK Inhibitors
  • Tyrosine Kinase (TKI) Inhibitors
  • Immunomodulators
  • 6.2. Global Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Others
  • 6.3. Global Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Immunotherapy
  • Chemotherapy
  • Others

7. Colorectal Cancer Drugs Market Regional And Country Analysis

  • 7.1. Global Colorectal Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Colorectal Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Colorectal Cancer Drugs Market

  • 8.1. Asia-Pacific Colorectal Cancer Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Colorectal Cancer Drugs Market

  • 9.1. China Colorectal Cancer Drugs Market Overview
  • 9.2. China Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Colorectal Cancer Drugs Market

  • 10.1. India Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Colorectal Cancer Drugs Market

  • 11.1. Japan Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Colorectal Cancer Drugs Market

  • 12.1. Australia Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Colorectal Cancer Drugs Market

  • 13.1. Indonesia Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Colorectal Cancer Drugs Market

  • 14.1. South Korea Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Colorectal Cancer Drugs Market

  • 15.1. Western Europe Colorectal Cancer Drugs Market Overview
  • 15.2. Western Europe Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Colorectal Cancer Drugs Market

  • 16.1. UK Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Colorectal Cancer Drugs Market

  • 17.1. Germany Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Colorectal Cancer Drugs Market

  • 18.4. France Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Colorectal Cancer Drugs Market

  • 19.1. Eastern Europe Colorectal Cancer Drugs Market Overview
  • 19.2. Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Colorectal Cancer Drugs Market

  • 20.1. Russia Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Colorectal Cancer Drugs Market

  • 21.1. North America Colorectal Cancer Drugs Market Overview
  • 21.2. North America Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Colorectal Cancer Drugs Market

  • 22.1. USA Colorectal Cancer Drugs Market Overview
  • 22.2. USA Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Colorectal Cancer Drugs Market

  • 23.1. South America Colorectal Cancer Drugs Market Overview
  • 23.2. South America Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Colorectal Cancer Drugs Market

  • 24.1. Brazil Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Colorectal Cancer Drugs Market

  • 25.1. Middle East Colorectal Cancer Drugs Market Overview
  • 25.2. Middle East Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Colorectal Cancer Drugs Market

  • 26.1. Africa Colorectal Cancer Drugs Market Overview
  • 26.2. Africa Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Colorectal Cancer Drugs Market Competitive Landscape And Company Profiles

  • 27.1. Colorectal Cancer Drugs Market Competitive Landscape
  • 27.2. Colorectal Cancer Drugs Market Company Profiles
    • 27.2.1. Merck & Co. Inc
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Roche
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Sanofi
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Amgen
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. PFIZER, INC.
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Colorectal Cancer Drugs Pipeline Analysis

29. Key Mergers And Acquisitions In The Colorectal Cancer Drugs Market

30. Colorectal Cancer Drugs Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer